RxDoctor Payments Data

Juliana Wilking-Johnson, MD

Geriatric Medicine · Westminster, CONPI 1285089052

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Lilly USA, LLC at 27.2% of the total. 2025 is the largest year on record at $124, 4.5 times the $28 reported in 2022.

$249in general payments, 2019–2025

Across 13 payments — averaging $19.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$68
  • Hologic Sales And Service, LLC$43
  • Amgen$30
  • Dexcom, Inc.$25
  • Exact Sciences$22
  • Insulet Corporation$21
  • plus $40 from 3 others

What the payments were for

  • Food & beverage$249100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$249 in reported general payments places this provider in the 70th percentile of 74 geriatric medicine providers in Colorado.

See all geriatric medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$41,257
Medicare patients
103
Services billed
454

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban53$76,041
MounjaroTirzepatide30$40,417
JardianceEmpagliflozin23$37,303
Glatiramer Acetate11$33,005
Spiriva RespimatTiotropium Bromide30$20,511
MyrbetriqMirabegron31$20,134
TrulicityDulaglutide15$19,897
XareltoRivaroxaban11$12,912
SymbicortBudesonide/Formoterol Fumarate14$6,541
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$6,246
Albuterol Sulfate HfaAlbuterol Sulfate93$2,629
Atorvastatin Calcium294$2,585
Celecoxib14$2,231
Rosuvastatin Calcium155$2,173
Omeprazole125$2,141

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$68$60,31445 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 74 geriatric medicine providers in Colorado.

Other geriatric medicine in Westminster

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →